NCT05044533View on ClinicalTrials.gov

A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Atrial Fibrillation
Trial Locations (1)

SA2 8PP

Local Institution - 0001, Swansea

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05044533 - A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF) | Biotech Hunter | Biotech Hunter